Histon LS Syrup is a combination pharmaceutical formulation containing Ambroxol 30mg, Levosalbutamol 1mg, and Guaifenesin 50mg per dose, designed for the management of respiratory conditions characterized by mucus hypersecretion, bronchospasm, and cough. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Levosalbutamol, a selective β2-adrenergic receptor agonist, provides bronchodilation by relaxing the smooth muscles of the bronchial airways, which helps alleviate bronchospasm and improve airflow in obstructive pulmonary diseases such as asthma and chronic obstructive pulmonary disease (COPD). Guaifenesin serves as an expectorant, promoting the thinning and loosening of mucus, which aids in productive cough and enhances the clearance of secretions. Histon LS Syrup is indicated for symptomatic relief in conditions such as acute and chronic bronchitis, asthma exacerbations, and other respiratory tract infections where mucus congestion and bronchoconstriction are present. The syrup formulation allows for ease of administration, particularly in pediatric and geriatric populations. It is essential to use this medication under medical supervision, considering contraindications and potential drug interactions. Adverse effects may include gastrointestinal discomfort, tremors, or hypersensitivity reactions, and patients should report any unusual symptoms promptly.